Logo image of NXRT

NEXPOINT RESIDENTIAL (NXRT) Stock Fundamental Analysis

NYSE:NXRT - New York Stock Exchange, Inc. - US65341D1028 - REIT - Currency: USD

31.11  -0.02 (-0.06%)

After market: 31.11 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NXRT. NXRT was compared to 20 industry peers in the Residential REITs industry. NXRT may be in some trouble as it scores bad on both profitability and health. NXRT is valued expensive and it does not seem to be growing. NXRT also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NXRT had negative earnings in the past year.
In the past year NXRT had a positive cash flow from operations.
NXRT had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NXRT had a positive operating cash flow.
NXRT Yearly Net Income VS EBIT VS OCF VS FCFNXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

The Return On Assets of NXRT (-2.68%) is worse than 90.00% of its industry peers.
NXRT has a Return On Equity of -14.29%. This is amonst the worse of the industry: NXRT underperforms 85.00% of its industry peers.
With a Return On Invested Capital value of 1.22%, NXRT is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
NXRT had an Average Return On Invested Capital over the past 3 years of 1.37%. This is in line with the industry average of 2.62%.
Industry RankSector Rank
ROA -2.68%
ROE -14.29%
ROIC 1.22%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
NXRT Yearly ROA, ROE, ROICNXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of NXRT has declined.
With a Operating Margin value of 11.11%, NXRT is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of NXRT has grown nicely.
Looking at the Gross Margin, with a value of 62.76%, NXRT is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of NXRT has declined.
Industry RankSector Rank
OM 11.11%
PM (TTM) N/A
GM 62.76%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
NXRT Yearly Profit, Operating, Gross MarginsNXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NXRT is destroying value.
NXRT has less shares outstanding than it did 1 year ago.
NXRT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NXRT has a worse debt to assets ratio.
NXRT Yearly Shares OutstandingNXRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NXRT Yearly Total Debt VS Total AssetsNXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.44, we must say that NXRT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.44, NXRT is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
The Debt to FCF ratio of NXRT is 32.74, which is on the high side as it means it would take NXRT, 32.74 years of fcf income to pay off all of its debts.
NXRT's Debt to FCF ratio of 32.74 is fine compared to the rest of the industry. NXRT outperforms 65.00% of its industry peers.
NXRT has a Debt/Equity ratio of 4.22. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NXRT (4.22) is worse than 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.22
Debt/FCF 32.74
Altman-Z 0.44
ROIC/WACC0.16
WACC7.83%
NXRT Yearly LT Debt VS Equity VS FCFNXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.03 indicates that NXRT should not have too much problems paying its short term obligations.
NXRT's Current ratio of 1.03 is fine compared to the rest of the industry. NXRT outperforms 80.00% of its industry peers.
NXRT has a Quick Ratio of 1.03. This is a normal value and indicates that NXRT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.03, NXRT is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
NXRT Yearly Current Assets VS Current LiabilitesNXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1

3. Growth

3.1 Past

NXRT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -212.21%.
NXRT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -65.41% yearly.
The Revenue has decreased by -6.02% in the past year.
NXRT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.48% yearly.
EPS 1Y (TTM)-212.21%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%-170%
Revenue 1Y (TTM)-6.02%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-17.9%

3.2 Future

Based on estimates for the next years, NXRT will show a very negative growth in Earnings Per Share. The EPS will decrease by -285.03% on average per year.
Based on estimates for the next years, NXRT will show a small growth in Revenue. The Revenue will grow by 2.48% on average per year.
EPS Next Y-6313.48%
EPS Next 2Y-682.05%
EPS Next 3Y-285.03%
EPS Next 5YN/A
Revenue Next Year-1.83%
Revenue Next 2Y1.67%
Revenue Next 3Y3.02%
Revenue Next 5Y2.48%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NXRT Yearly Revenue VS EstimatesNXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
NXRT Yearly EPS VS EstimatesNXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

NXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NXRT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXRT Price Earnings VS Forward Price EarningsNXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NXRT is valued a bit cheaper than 65.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, NXRT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.61
EV/EBITDA 17.84
NXRT Per share dataNXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A cheap valuation may be justified as NXRT's earnings are expected to decrease with -285.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-682.05%
EPS Next 3Y-285.03%

7

5. Dividend

5.1 Amount

NXRT has a Yearly Dividend Yield of 6.55%, which is a nice return.
Compared to an average industry Dividend Yield of 4.83, NXRT pays a better dividend. On top of this NXRT pays more dividend than 90.00% of the companies listed in the same industry.
NXRT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.55%

5.2 History

On average, the dividend of NXRT grows each year by 10.88%, which is quite nice.
NXRT has paid a dividend for at least 10 years, which is a reliable track record.
NXRT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)10.88%
Div Incr Years9
Div Non Decr Years9
NXRT Yearly Dividends per shareNXRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of NXRT are negative and hence is the payout ratio. NXRT will probably not be able to sustain this dividend level.
DP-104.31%
EPS Next 2Y-682.05%
EPS Next 3Y-285.03%
NXRT Yearly Income VS Free CF VS DividendNXRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

NEXPOINT RESIDENTIAL

NYSE:NXRT (8/15/2025, 8:04:00 PM)

After market: 31.11 0 (0%)

31.11

-0.02 (-0.06%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners77.34%
Inst Owner Change0.13%
Ins Owners13.35%
Ins Owner Change14.35%
Market Cap788.95M
Analysts72.86
Price Target38.67 (24.3%)
Short Float %1.61%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield 6.55%
Yearly Dividend1.93
Dividend Growth(5Y)10.88%
DP-104.31%
Div Incr Years9
Div Non Decr Years9
Ex-Date09-15 2025-09-15 (0.51)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.59%
Min EPS beat(2)8.72%
Max EPS beat(2)18.46%
EPS beat(4)2
Avg EPS beat(4)-44.01%
Min EPS beat(4)-176.12%
Max EPS beat(4)18.46%
EPS beat(8)5
Avg EPS beat(8)52.88%
EPS beat(12)6
Avg EPS beat(12)9.02%
EPS beat(16)9
Avg EPS beat(16)54.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-1.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.64%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)-1.36%
Revenue beat(8)2
Avg Revenue beat(8)3.22%
Revenue beat(12)3
Avg Revenue beat(12)1.86%
Revenue beat(16)6
Avg Revenue beat(16)1.46%
PT rev (1m)-4.61%
PT rev (3m)-11.56%
EPS NQ rev (1m)-7.11%
EPS NQ rev (3m)-24.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.13%
Revenue NQ rev (1m)-0.8%
Revenue NQ rev (3m)-1.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.1
P/FCF 17.61
P/OCF 9.57
P/B 2.27
P/tB 2.27
EV/EBITDA 17.84
EPS(TTM)-1.93
EYN/A
EPS(NY)-1.18
Fwd EYN/A
FCF(TTM)1.77
FCFY5.68%
OCF(TTM)3.25
OCFY10.45%
SpS10.03
BVpS13.72
TBVpS13.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.68%
ROE -14.29%
ROCE 1.55%
ROIC 1.22%
ROICexc 1.23%
ROICexgc 1.25%
OM 11.11%
PM (TTM) N/A
GM 62.76%
FCFM 17.62%
ROA(3y)0.58%
ROA(5y)1.05%
ROE(3y)2.48%
ROE(5y)4.62%
ROIC(3y)1.37%
ROIC(5y)1.09%
ROICexc(3y)1.38%
ROICexc(5y)1.1%
ROICexgc(3y)1.43%
ROICexgc(5y)1.13%
ROCE(3y)1.73%
ROCE(5y)1.38%
ROICexcg growth 3Y22.72%
ROICexcg growth 5Y15.26%
ROICexc growth 3Y21.87%
ROICexc growth 5Y14.79%
OM growth 3Y12.71%
OM growth 5Y7.38%
PM growth 3Y-65.59%
PM growth 5Y-62.11%
GM growth 3Y-12.32%
GM growth 5Y-7.43%
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.22
Debt/FCF 32.74
Debt/EBITDA 11.67
Cap/Depr 38.64%
Cap/Sales 14.8%
Interest Coverage 0.3
Cash Conversion 65.61%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 0.44
F-Score4
WACC7.83%
ROIC/WACC0.16
Cap/Depr(3y)106.97%
Cap/Depr(5y)173.62%
Cap/Sales(3y)38.98%
Cap/Sales(5y)66.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-212.21%
EPS 3Y-70.76%
EPS 5Y-65.41%
EPS Q2Q%-170%
EPS Next Y-6313.48%
EPS Next 2Y-682.05%
EPS Next 3Y-285.03%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.02%
Revenue growth 3Y5.81%
Revenue growth 5Y7.48%
Sales Q2Q%-17.9%
Revenue Next Year-1.83%
Revenue Next 2Y1.67%
Revenue Next 3Y3.02%
Revenue Next 5Y2.48%
EBIT growth 1Y-24.73%
EBIT growth 3Y19.26%
EBIT growth 5Y15.4%
EBIT Next Year18458.6%
EBIT Next 3Y496.24%
EBIT Next 5Y286.19%
FCF growth 1Y183.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.62%
OCF growth 3Y0.14%
OCF growth 5Y7.45%